Skip to main content

Open Access 23.03.2024 | Case Report

Verrucous gastritis-like lesion in intramucosal Helicobacter pylori-uninfected signet ring cell carcinoma with poorly differentiated adenocarcinoma

verfasst von: Hiroki Takemoto, Takahiro Kotachi, Hajime Teshima, Hirosato Tamari, Akiyoshi Tsuboi, Hidenori Tanaka, Ken Yamashita, Yuji Urabe, Akira Ishikawa, Shiro Oka

Erschienen in: Clinical Journal of Gastroenterology

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN

Abstract

In Japan, accessible Helicobacter pylori (Hp) eradication therapy is associated with an increase in the prevalence of gastric cancers (GCs) in Hp uninfected stomachs. Signet ring cell carcinoma (SRCC) is the most common of these GCs. Intramucosal SRCC with poorly differentiated adenocarcinoma (PDA) occurring in Hp uninfected gastric mucosa is rare; furthermore, many Hp uninfected pure SRCCs exhibit discoloration and flat or slightly depressed lesions, and morphological elevation is relatively rare. We report a case of intramucosal SRCC with PDA with an elevated, verrucous gastritis-like lesion in a 57-year-old male patient. In the present case, the PDA area showed dense tumor cell growth and coexisting desmoplastic and fibrotic reactions. Histopathology and immunohistochemical staining identified extensive fibromuscular obliteration with smooth muscle bundles extending from the muscularis mucosa into the lamina propria. The patient underwent curative endoscopic submucosal dissection. The reporting and analysis of such rare cases may lead to a better understanding of the characteristics of advanced Hp uninfected GCs.
Hinweise

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Introduction

The World Health Organization’s International Agency for Research on Cancer has classified Helicobacter pylori (Hp) as a carcinogen that causes gastric cancer (GC) [1]. National health insurance coverage for Hp eradication therapy for the treatment of Hp associated chronic gastritis has become available in Japan. As a result, the number of patients with reduced Hp infected status and the relative number of cases of Hp uninfected GC has increased. The frequency of Hp uninfected GC ranges from 0.4 to 5.0% [27]. Among these cases, signet ring cell carcinoma (SRCC), characterized by a discolored and flat or slightly depressed lesion, accounts for over 90% of cases [8]. SRCC in Hp uninfected gastric mucosa shows lower proliferative activity, lesser extensive spread, and slower progression than SRCC in Hp infected gastric mucosa [4]. However, although extremely rare, cases of advanced Hp uninfected GC have also been reported [9, 10]. The invasive potential of SRCC increases after TP53 mutation, and the cancer progresses to poorly differentiated adenocarcinoma (PDA) [11]. We report a case involving a small, flat-elevated, depressed SRCC lesion with PDA occurring in Hp uninfected gastric mucosa that was curatively resected by endoscopic submucosal dissection (ESD).

Case report

The patient was a 57-year-old male. He had no symptoms and was diagnosed with early GC. A depressed lesion of 10 mm in diameter located at the greater curvature of the gastric antrum was found during a routine upper gastrointestinal endoscopy procedure. He was referred to Hiroshima University Hospital, Hiroshima, Japan, after a biopsy indicating SRCC. The patient had type 2 diabetes mellitus, dyslipidemia, and postoperative renal cell carcinoma. His family history included rectal cancer in his mother and no history of GC. He smoked 15 cigarettes (Brinkman index = 600) and drank 60 mL of whiskey per day for 40 years. The patient had no history of Hp eradication therapy. Hp stool antigen, urea breath, and serum immunoglobulin G antibody tests were negative. An EGD showed a regular arrangement of collecting venules (RAC) [12] in the entire gastric fundic gland area and no atrophic mucosal change. The histopathological results of five biopsies previously performed at our hospital did not show mucosal atrophy. From the above laboratory data, endoscopic findings, and histopathological findings, we concluded that the stomach had a normal gastric mucosa without Hp infection. The patient underwent EGD annually until 3 years before being referred to our hospital. One year before being referred to our hospital, an EGD revealed an 8 mm poorly demarcated, reddish, elevated, verrucous gastritis-like lesion under linked color imaging (LCI). This lesion was located at the greater curvature of the gastric antrum and was a single lesion with erosion at the top (Fig. 1a). No biopsy was performed in this EGD. One month before being referred to our hospital, an EGD revealed that the lesion’s appearance was similar to that of 1 year ago. However, the lesion changed to a two-hump shape (Fig. 1b). Biopsy was performed from a lesion on the oral side and indicated an SRCC. Compared to the previous EGD, the lesion was slightly smaller in height, revealing a 10 mm poorly demarcated elevated verrucous gastritis-like lesion with a slight depression at the top (Fig. 1c). Application of indigo carmine sprinkling solution clearly showed the depressed area. However, this lesion did not show encroachment of the fold (Fig. 1d). Moreover, the lesion had an unclear demarcation line (BLI) under blue laser imaging and was partially covered with normal mucosa (Fig. 1e). The lesion was elevated with a swollen glandular structure, and a slightly depressed area in the dilated intervening part was observed (Fig. 1e, f). We assumed this lesion to be a malignant tumor with 0–IIa+IIc according to the Paris classification. The lesion was small, neither thickened nor hard, and was diagnosed as intramucosal carcinoma. And negative biopsy results were collected from four sites surrounding the lesion (5–10 mm from the tumor margin). Therefore, we performed ESD.
The resected specimen measured 35×30 mm, and the lesion measured 18×16 mm. Figure 2a shows the histopathological mapping of the resected specimen, wherein the yellow and red lines indicated pure SRCC and SRCC with PDA, respectively. The green line indicates fibromuscular obliteration strong positive. Hematoxylin and Eosin (HE) staining showed that the SRCC was localized to the lamina propria and covered by non-neoplastic foveolar epithelium, and the SRCC developed toward the luminal side, forming a lesion that was taller than the surrounding non-neoplastic mucosa. (Fig. 2b). In addition, the slightly depressed area at the top of the lesion contained a higher density of tumor cells compared with the surrounding area and was associated with the PDA component, which was also covered by non-neoplastic foveolar epithelium (Fig. 2c, d). In Fig. 2d, the blue arrow indicated dense cancer cell growth and coexistent desmoplastic and fibrotic reactions. No erosions or tumor cell exposure on the surface was observed. Immunohistochemical staining showed that tumor cells could be divided into two layers, superficial and deep. The SRCC area and foveolar epithelium, spread over the superficial layer, were MUC5AC-positive (Fig. 3a). The deep PDA area, extending to the middle intramucosal layer, was Ki-67-positive (Fig. 3b). The part of PDA area and pyloric glands and mucous neck cells, spread in the deep layer, were MUC6-positive (Fig. 3c). This layered structure was similar to that of the normal gastric mucosa. In addition, the deep PDA cells were positive for Ki-67 (Fig. 3b) and p53 (Fig. 3d); however, very few SRCC cells were Ki-67- and p53-positive. Both components were negative for MUC2 and CD10. Particularly, the p53-positive PDA cell rate was more than 50%. In the background non-neoplastic mucosa surrounding the lesion and the cancer lesion, Masson trichrome (Fig. 3e) and anti-α-smooth muscle actin (Fig. 3g) staining revealed that extensive fibromuscular obliteration was characterized by dense, proliferative, thin muscle bundles, which extended from the muscularis mucosa to the lamina propria; however, some areas were weakly positive (Fig. 3f, h). In the ESD specimen, the surrounding mucosa was almost entirely composed of pyloric glands. Thus, this lesion was considered an intramucosal SRCC concomitant with PDA, had clear resection margins, and had no lymphovascular invasion. Resection was considered curative. Additional surgical resection was not needed, the patient chose to undergo annual endoscopic surveillance.

Discussion

This case had two unique features. First, SRCC with PDA was detected. Hp uninfected undifferentiated-type GC (UD-GC) is present in most SRCC cases [3, 5, 13]. In particular, cases of pure Hp uninfected SRCC exhibit intramucosal lesions [8]. Many cases of advanced GC, including Hp exposed UD-GC, exhibit PDA. In a mouse model, p53 loss promotes cell growth and anti-apoptotic events [9] and is associated with the progression of intramucosal UD-GC to advanced UD-GC. Therefore, intramucosal carcinoma cells are SRCC but the invasive area changes to PDA, and mutations, such as p53 loss, likely result in increased invasive potential and morphological changes [14]. In this patient, immunohistochemical staining for p53 in the PDA area was positive. PDA can invade the submucosa, and curative resection of intramucosal carcinoma can be achieved via early identification and treatment of the lesion. In addition, the layered structure was similar to that of normal gastric glands. In the intramucosal layer, SRCC often exhibits a double-layer structure (DLS) [15]. Natsagdorj et al. [16]. reported that the presence of the DLS markedly decreased with submucosal invasion. The lesion in our case exhibited a DLS but the increasing PDA area size may have compromised the maintenance of the DLS. Very few cases of Hp uninfected advanced GC have been reported, and histopathological examination in these cases shows either SRCC, SRCC with PDA, or pure PDA [17]. The other important feature of this lesion was elevation. Many Hp uninfected pure SRCCs exhibit discoloration and flat or slightly depressed lesions [8]. However, only a few cases exhibit elevated lesions [1820]. Kishi et al. [18]. reported that the mechanism underlying the protrusion of UD-GC lesions has not been determined but four possibilities have been proposed: formation of fibrous tissue or mucinous nodules due to cancer invasion into the deep layer of the gastric mucosa, dense growth of cancer cells, proliferation of UD-GC in a gastric hyperplastic polyp, or fibromuscular obliteration of the muscularis propria. We think that the elevated lesion occurred due to two factors. The PDA area showed dense cancer cell growth and coexistent desmoplastic and fibrotic reactions, which may have caused the elevation of the lesion. The lesion was located in the gastric antrum, and fibromuscular obliteration of the muscularis propria caused an elevated lesion. Fibromuscular obliteration of the muscularis propria is reported in conditions such as rectal mucosal prolapse syndrome and occurs when smooth muscle bundles extend from the muscularis mucosa into the lamina propria [21]. In our case, immunohistochemical staining indicated fibromuscular obliteration around the pyloric glands in the background mucosa surrounding the lesion.
Among Hp uninfected GCs, intestinal-type differentiated carcinoma is known as a typical type of Hp uninfected GC arising in the pyloric gland region and is similar to verrucous gastritis-like lesion. This patient was referred to our hospital after a biopsy indicated SRCC. It thus remains to be discussed how this case can be differentiated from intestinal-type differentiated carcinoma or verrucous gastritis (VG). Intestinal-type differentiated carcinoma in Hp uninfected GC has been reported to show flat, elevated, or depressed lesions [22] and a single erosion [23]. Irregular microvascular patterns on magnifying endoscopy with narrow-band imaging (ME-NBI) can help distinguish differentiated tubular adenocarcinoma from the surrounding erosions [24, 25], while other ME-NBI findings have reported an absence of a clear DL or an irregular microvessel/surface pattern [23]. Moreover, in VG, the lesions are arranged along longitudinal folds converging toward the pylorus ring. Tsuji et al. [26] reported that Hp negativity was independently associated with VG regardless of the history of Hp eradication. Moreover, when endoscopic findings show flat elevated or depressed lesions, the differential diagnosis should include VG or early GC. In the present case, the lesion was partially covered with normal mucosa and did not show irregular microvascular pattern under BLI. Furthermore, elevated intramucosal UD-GC in Hp uninfected cases are rare case. A few cases [1820, 27], wherein the lesions were macroscopically divided into protruding or submucosal tumor-like (SMT-like). And SMT-like lesions were covered with normal mucosa, did not show a clear DL or an irregular microvessel/ surface pattern on ME-NBI [1820]. From the above findings it is clear that in many cases similar endoscopic findings are present, and although some cases can be differentiated by ME-NBI, this is not possible in all cases. In addition, elevated intramucosal UD-GCs in Hp uninfected cases are so rare that it is not well known; hence, it is difficult to differentiate the lesion from intestinal-type differentiated carcinoma and VG. Therefore, when a single lesion is observed in the antrum, a biopsy of the lesion should be performed. Additional, in this case, endoscopic findings of the extension were difficult by covered normal mucosa, we performed negative biopsies. In this resected specimen, tumor cells were present consistent with an elevated lesion. UD-GC incidence of positive lateral margins in en bloc specimens resected by ESD has been reported to be 27.3% [28], and previous studies reveal that the predictive factors for inaccurate determination of the lateral extent of early gastric cancer indicated for ESD include UD-GC [29, 30]. And it was reported that it would be difficult to delineate diagnostic demarcation, even using magnifying endoscopy with NBI, in cases with a narrower inter-crypt distance in the cancerous region because of the scarcity of cancer cells as well as in cases with pronounced inflammatory cell infiltration [31]. Negative biopsies help determine the lateral extent of the lesion [3234]. Although we need to pay attention to the dilated intervening part [31, 35], elevated intramucosal UD-GCs in Hp uninfected cases are so rare, there is no sufficient consensus, we thought that need for negative biopsies in surrounding the lesion (5–10 mm from the tumor margin).
In conclusion, we reported the case of a patient with an elevated, verrucous gastritis-like lesion who underwent ESD. The histopathological diagnosis was intramucosal SRCC with PDA with negative lymphovascular invasion and clear resection margins. The resection was curative. This report may improve our understanding of the characteristics of rare, advanced Hp uninfected GCs.

Acknowledgements

We are grateful to the present staff at the gastroenterology and pathology laboratories, for their valuable support during. We also would like to thank Editage (https://​app.​editage.​jp/​) for the English language editing.

Declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Human rights

All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008.
This study does not contain identifying information of the patients.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

e.Med Innere Medizin

Kombi-Abonnement

Mit e.Med Innere Medizin erhalten Sie Zugang zu CME-Fortbildungen des Fachgebietes Innere Medizin, den Premium-Inhalten der internistischen Fachzeitschriften, inklusive einer gedruckten internistischen Zeitschrift Ihrer Wahl.

e.Med Allgemeinmedizin

Kombi-Abonnement

Mit e.Med Allgemeinmedizin erhalten Sie Zugang zu allen CME-Fortbildungen und Premium-Inhalten der allgemeinmedizinischen Zeitschriften, inklusive einer gedruckten Allgemeinmedizin-Zeitschrift Ihrer Wahl.

Literatur
1.
Zurück zum Zitat IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Schistosomes, liver flukes and Helicobacter pylori IARC. Monogr Eval Carcinog Risks Hum 1994;61:241 IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Schistosomes, liver flukes and Helicobacter pylori IARC. Monogr Eval Carcinog Risks Hum 1994;61:241
2.
Zurück zum Zitat Ono S, Kato M, Suzuki M, et al. Frequency of Helicobacter pylori-negative gastric cancer and gastric mucosal atrophy in a Japanese endoscopic submucosal dissection series including histological, endoscopic and serological atrophy. Digestion. 2012;86:59–65.CrossRefPubMed Ono S, Kato M, Suzuki M, et al. Frequency of Helicobacter pylori-negative gastric cancer and gastric mucosal atrophy in a Japanese endoscopic submucosal dissection series including histological, endoscopic and serological atrophy. Digestion. 2012;86:59–65.CrossRefPubMed
3.
Zurück zum Zitat Matsuo T, Ito M, Takata S, et al. Low prevalence of Helicobacter pylori-negative gastric cancer among Japanese. Helicobacter. 2011;16:415–9.CrossRefPubMed Matsuo T, Ito M, Takata S, et al. Low prevalence of Helicobacter pylori-negative gastric cancer among Japanese. Helicobacter. 2011;16:415–9.CrossRefPubMed
4.
Zurück zum Zitat Horiuchi Y, Fujisaki J, Yamamoto N, et al. Biological behavior of the intramucosal Helicobacter pylori-negative undifferentiated-type early gastric cancer: comparison with Helicobacter pylori-positive early gastric cancer. Gastric Cancer. 2016;19:160–5.CrossRefPubMed Horiuchi Y, Fujisaki J, Yamamoto N, et al. Biological behavior of the intramucosal Helicobacter pylori-negative undifferentiated-type early gastric cancer: comparison with Helicobacter pylori-positive early gastric cancer. Gastric Cancer. 2016;19:160–5.CrossRefPubMed
5.
Zurück zum Zitat Kato S, Matsukura N, Tsukada K, et al. Helicobacter pylori infection-negative gastric cancer in Japanese hospital patients: incidence and pathological characteristics. Cancer Sci. 2007;98:790–4.CrossRefPubMed Kato S, Matsukura N, Tsukada K, et al. Helicobacter pylori infection-negative gastric cancer in Japanese hospital patients: incidence and pathological characteristics. Cancer Sci. 2007;98:790–4.CrossRefPubMed
6.
Zurück zum Zitat Yoon H, Kim N, Lee HS, et al. Helicobacter pylori-negative gastric cancer in South Korea: incidence and clinicopathologic characteristics. Helicobacter. 2011;16:382–8.CrossRefPubMed Yoon H, Kim N, Lee HS, et al. Helicobacter pylori-negative gastric cancer in South Korea: incidence and clinicopathologic characteristics. Helicobacter. 2011;16:382–8.CrossRefPubMed
7.
Zurück zum Zitat Yamada A, Kaise M, Inoshita N, et al. Characterization of Helicobacter pylori uninfected early gastric cancers. Digestion. 2018;98:127–34.CrossRefPubMed Yamada A, Kaise M, Inoshita N, et al. Characterization of Helicobacter pylori uninfected early gastric cancers. Digestion. 2018;98:127–34.CrossRefPubMed
8.
Zurück zum Zitat Yamamoto Y, Fujisaki J, Omae M, et al. Helicobacter pylori-negative gastric cancer: characteristics and endoscopic findings. Dig Endosc. 2015;27:551–61.CrossRefPubMed Yamamoto Y, Fujisaki J, Omae M, et al. Helicobacter pylori-negative gastric cancer: characteristics and endoscopic findings. Dig Endosc. 2015;27:551–61.CrossRefPubMed
9.
Zurück zum Zitat Okano A, Kato S, Ohana M. Helicobacter pylori-negative gastric cancer: advanced-stage undifferentiated adenocarcinoma located in the pyloric gland area. Clin J Gastroenterol. 2017;10:13–7.CrossRefPubMed Okano A, Kato S, Ohana M. Helicobacter pylori-negative gastric cancer: advanced-stage undifferentiated adenocarcinoma located in the pyloric gland area. Clin J Gastroenterol. 2017;10:13–7.CrossRefPubMed
10.
11.
Zurück zum Zitat Shimada S, Mimata A, Sekine M, et al. Synergistic tumour suppressor activity of E-cadherin and p53 in a conditional mouse model for metastatic diffuse-type gastric cancer. Gut. 2012;61:344–53.CrossRefPubMed Shimada S, Mimata A, Sekine M, et al. Synergistic tumour suppressor activity of E-cadherin and p53 in a conditional mouse model for metastatic diffuse-type gastric cancer. Gut. 2012;61:344–53.CrossRefPubMed
12.
Zurück zum Zitat Yagi K, Aruga Y, Nakamura A, et al. Regular arrangement of collecting venules (RAC): a characteristic endoscopic feature of Helicobacter pylori-negative normal stomach and its relationship with esophago-gastric adenocarcinoma. J Gastroenterol. 2005;40:443–52.CrossRefPubMed Yagi K, Aruga Y, Nakamura A, et al. Regular arrangement of collecting venules (RAC): a characteristic endoscopic feature of Helicobacter pylori-negative normal stomach and its relationship with esophago-gastric adenocarcinoma. J Gastroenterol. 2005;40:443–52.CrossRefPubMed
13.
Zurück zum Zitat Kakinoki R, Kushima R, Matsubara A. Re-evaluation of histogenesis of gastric carcinomas: a comparative histopathological study between Helicobacter pylori-negative and H. pylori-positive cases. Dig Dis Sci. 2009;54:614–20.CrossRefPubMed Kakinoki R, Kushima R, Matsubara A. Re-evaluation of histogenesis of gastric carcinomas: a comparative histopathological study between Helicobacter pylori-negative and H. pylori-positive cases. Dig Dis Sci. 2009;54:614–20.CrossRefPubMed
14.
Zurück zum Zitat Kiso M, Urabe Y, Ito M, et al. Clinical and genomic characteristics of mucosal signet-ring cell carcinoma in Helicobacter pylori-uninfected stomach. BMC Gastroenterol. 2020;20:243.CrossRefPubMedPubMedCentral Kiso M, Urabe Y, Ito M, et al. Clinical and genomic characteristics of mucosal signet-ring cell carcinoma in Helicobacter pylori-uninfected stomach. BMC Gastroenterol. 2020;20:243.CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Sugihara H, Hattori T, Fukuda M, et al. Cell proliferation and differentiation in intramucosal and advanced signet ring cell carcinomas of the human stomach. Virchows Arch A Pathol Anat Histopathol. 1987;411:117–27.CrossRefPubMed Sugihara H, Hattori T, Fukuda M, et al. Cell proliferation and differentiation in intramucosal and advanced signet ring cell carcinomas of the human stomach. Virchows Arch A Pathol Anat Histopathol. 1987;411:117–27.CrossRefPubMed
16.
Zurück zum Zitat Natsagdorj L, Sugihara H, Bamba M, et al. Intratumoural heterogeneity of intestinal expression reflects environmental induction and progression-related loss of induction in undifferentiated-type gastric carcinomas. Histopathology. 2008;53:685–97.CrossRefPubMed Natsagdorj L, Sugihara H, Bamba M, et al. Intratumoural heterogeneity of intestinal expression reflects environmental induction and progression-related loss of induction in undifferentiated-type gastric carcinomas. Histopathology. 2008;53:685–97.CrossRefPubMed
17.
Zurück zum Zitat Yoshimura D, Yoshimura R, Kato S, et al. Clinical and pathological characteristics of Helicobacter pylori-uninfected signet-ring cell cancer of the stomach an analysis of case series. Stomach Intestine. 2020;55:1051–60. Yoshimura D, Yoshimura R, Kato S, et al. Clinical and pathological characteristics of Helicobacter pylori-uninfected signet-ring cell cancer of the stomach an analysis of case series. Stomach Intestine. 2020;55:1051–60.
18.
Zurück zum Zitat Kishi K, Adachi K, Sakamoto U. Gastric flat elevated undifferentiated signet-ring cell mucosal cancer lesion detected in a case without Helicobacter pylori infection. Intern Med. 2023;10:10332. Kishi K, Adachi K, Sakamoto U. Gastric flat elevated undifferentiated signet-ring cell mucosal cancer lesion detected in a case without Helicobacter pylori infection. Intern Med. 2023;10:10332.
19.
Zurück zum Zitat Misumi Y, Ichihara S, Nonaka K. Gastric signet-ring cell carcinoma that presented as an elevated lesion due to fibromuscular obliteration in the lamina propria. Case rep Gastrointest. 2021;2021:2887256. Misumi Y, Ichihara S, Nonaka K. Gastric signet-ring cell carcinoma that presented as an elevated lesion due to fibromuscular obliteration in the lamina propria. Case rep Gastrointest. 2021;2021:2887256.
20.
Zurück zum Zitat Shiratori Y, Ikeya T, Suzuki K, et al. The rare case of elevated signet ring cell gastric carcinoma with Helicobacter pylori uninfected mucosa. Clin J Gastroenterol. 2020;13:736–9.CrossRefPubMed Shiratori Y, Ikeya T, Suzuki K, et al. The rare case of elevated signet ring cell gastric carcinoma with Helicobacter pylori uninfected mucosa. Clin J Gastroenterol. 2020;13:736–9.CrossRefPubMed
21.
Zurück zum Zitat Murata M, Sugimoto M, Ban H, et al. Cap polyposis refractory to Helicobacter pylori eradication treated with endoscopic submucosal dissection. World J Gastrointest Endosc. 2017;9:529–34.CrossRefPubMedPubMedCentral Murata M, Sugimoto M, Ban H, et al. Cap polyposis refractory to Helicobacter pylori eradication treated with endoscopic submucosal dissection. World J Gastrointest Endosc. 2017;9:529–34.CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Murawaki Y, Yashima K, Horie S, et al. Helicobacter pylori-negative gastric adenocarcinoma mimicking VG in the antrum: a case report and literature review. Intern Med. 2023;62:2063–9.CrossRefPubMed Murawaki Y, Yashima K, Horie S, et al. Helicobacter pylori-negative gastric adenocarcinoma mimicking VG in the antrum: a case report and literature review. Intern Med. 2023;62:2063–9.CrossRefPubMed
23.
Zurück zum Zitat Takita M, Ohata K, Inamoto R, et al. Endoscopic and histological feature of Helicobacter pylori-negative differentiated gastric adenocarcinoma arising in antrum. JGH Open. 2021;5:4770–5.CrossRef Takita M, Ohata K, Inamoto R, et al. Endoscopic and histological feature of Helicobacter pylori-negative differentiated gastric adenocarcinoma arising in antrum. JGH Open. 2021;5:4770–5.CrossRef
24.
Zurück zum Zitat Kotani S, Miyaoka Y, Fujiwara A, et al. Intestinal-type gastric adenocarcinoma without Helicobacter pylori infection successfully treated with endoscopic submucosal dissection. Clin J Gastroenterol. 2016;9:228–32.CrossRefPubMed Kotani S, Miyaoka Y, Fujiwara A, et al. Intestinal-type gastric adenocarcinoma without Helicobacter pylori infection successfully treated with endoscopic submucosal dissection. Clin J Gastroenterol. 2016;9:228–32.CrossRefPubMed
25.
Zurück zum Zitat Ozaki Y, Suto H, Nasaka T, et al. A case of Helicobacter pylori-negative intramucosal well-differentiated gastric adenocarcinoma with intestinal phenotype. Clin J Gastroenterol. 2015;8:18–21.CrossRefPubMed Ozaki Y, Suto H, Nasaka T, et al. A case of Helicobacter pylori-negative intramucosal well-differentiated gastric adenocarcinoma with intestinal phenotype. Clin J Gastroenterol. 2015;8:18–21.CrossRefPubMed
26.
Zurück zum Zitat Tsuji N, Umehara Y, Takenaka M, et al. Verrucous antral gastritis in relation to Helicobacter pylori infection, nutrition, and gastric atrophy. Gastroenterol Rep. 2019;8:293–8.CrossRef Tsuji N, Umehara Y, Takenaka M, et al. Verrucous antral gastritis in relation to Helicobacter pylori infection, nutrition, and gastric atrophy. Gastroenterol Rep. 2019;8:293–8.CrossRef
27.
Zurück zum Zitat Oura R, Katayama Y, Gyotoku Y, et al. A case of undifferentiated intramucosal gastric cancer that exhibited elevated type. Dokkyo J Med Sci. 2016;43:125–9. Oura R, Katayama Y, Gyotoku Y, et al. A case of undifferentiated intramucosal gastric cancer that exhibited elevated type. Dokkyo J Med Sci. 2016;43:125–9.
28.
Zurück zum Zitat Jeon HK, Lee SJ, Kim GH, et al. Endoscopic submucosal dissection for undifferentiated-type early gastric cancer: short- and long-term outcomes. Surg Endosc. 2018;32:1963–70.CrossRefPubMed Jeon HK, Lee SJ, Kim GH, et al. Endoscopic submucosal dissection for undifferentiated-type early gastric cancer: short- and long-term outcomes. Surg Endosc. 2018;32:1963–70.CrossRefPubMed
29.
Zurück zum Zitat Kakushima N, Ono H, Tanaka M, et al. Factors related to lateral margin positivity for cancer in gastric specimens of endoscopic submucosal dissection. Dig Endosc. 2011;23:227–32.CrossRefPubMed Kakushima N, Ono H, Tanaka M, et al. Factors related to lateral margin positivity for cancer in gastric specimens of endoscopic submucosal dissection. Dig Endosc. 2011;23:227–32.CrossRefPubMed
30.
Zurück zum Zitat Asada-Hirayama I, Kodashima S, Goto O, et al. Factors predictive of inaccurate determination of horizontal extent of intestinal-type early gastric cancers during endoscopic submucosal dissection: a retrospective analysis. Dig Endosc. 2013;25:593–600.CrossRefPubMed Asada-Hirayama I, Kodashima S, Goto O, et al. Factors predictive of inaccurate determination of horizontal extent of intestinal-type early gastric cancers during endoscopic submucosal dissection: a retrospective analysis. Dig Endosc. 2013;25:593–600.CrossRefPubMed
31.
Zurück zum Zitat Horiuchi Y, Fujisaki J, Yamamoto N, et al. Accuracy of diagnostic demarcation of undifferentiated-type early gastric cancers for magnifying endoscopy with narrow-band imaging: endoscopic submucosal dissection cases. Gastric Cancer. 2016;19:515–23.CrossRefPubMed Horiuchi Y, Fujisaki J, Yamamoto N, et al. Accuracy of diagnostic demarcation of undifferentiated-type early gastric cancers for magnifying endoscopy with narrow-band imaging: endoscopic submucosal dissection cases. Gastric Cancer. 2016;19:515–23.CrossRefPubMed
32.
Zurück zum Zitat Yamamoto Y, Fujisaki J, Hirasawa T, et al. Therapeutic outcomes of endoscopic submucosal dissection of undifferentiated-type intramucosal gastric cancer without ulceration and preoperatively diagnosed as 20 millimetres or less in diameter. Dig Endosc. 2010;22:112–8.CrossRefPubMed Yamamoto Y, Fujisaki J, Hirasawa T, et al. Therapeutic outcomes of endoscopic submucosal dissection of undifferentiated-type intramucosal gastric cancer without ulceration and preoperatively diagnosed as 20 millimetres or less in diameter. Dig Endosc. 2010;22:112–8.CrossRefPubMed
33.
Zurück zum Zitat Yoshimizu S, Yamamoto Y, Horiuchi Y, et al. A suitable marking method to achieve lateral margin negative in endoscopic submucosal dissection for undifferentiated-type early gastric cancer. Endosc Int Open. 2019;7:274–81.CrossRef Yoshimizu S, Yamamoto Y, Horiuchi Y, et al. A suitable marking method to achieve lateral margin negative in endoscopic submucosal dissection for undifferentiated-type early gastric cancer. Endosc Int Open. 2019;7:274–81.CrossRef
34.
Zurück zum Zitat Ono H, Yao K, Fujishiro M, et al. Guidelines for endoscopic submucosal dissection and endoscopic mucosal resection for early gastric cancer (second edition). Dig Endosc. 2021;33:4–20.CrossRefPubMed Ono H, Yao K, Fujishiro M, et al. Guidelines for endoscopic submucosal dissection and endoscopic mucosal resection for early gastric cancer (second edition). Dig Endosc. 2021;33:4–20.CrossRefPubMed
35.
Zurück zum Zitat Okada K, Fujisaki J, Kasuga A, et al. Diagnosis of undifferentiated-type early gastric cancers by magnification endoscopy with narrow-band imaging. J Gastroenterol Hepatol. 2011;26:1262–9.CrossRefPubMed Okada K, Fujisaki J, Kasuga A, et al. Diagnosis of undifferentiated-type early gastric cancers by magnification endoscopy with narrow-band imaging. J Gastroenterol Hepatol. 2011;26:1262–9.CrossRefPubMed
Metadaten
Titel
Verrucous gastritis-like lesion in intramucosal Helicobacter pylori-uninfected signet ring cell carcinoma with poorly differentiated adenocarcinoma
verfasst von
Hiroki Takemoto
Takahiro Kotachi
Hajime Teshima
Hirosato Tamari
Akiyoshi Tsuboi
Hidenori Tanaka
Ken Yamashita
Yuji Urabe
Akira Ishikawa
Shiro Oka
Publikationsdatum
23.03.2024
Verlag
Springer Nature Singapore
Erschienen in
Clinical Journal of Gastroenterology
Print ISSN: 1865-7257
Elektronische ISSN: 1865-7265
DOI
https://doi.org/10.1007/s12328-024-01952-9

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Aquatherapie bei Fibromyalgie wirksamer als Trockenübungen

03.05.2024 Fibromyalgiesyndrom Nachrichten

Bewegungs-, Dehnungs- und Entspannungsübungen im Wasser lindern die Beschwerden von Patientinnen mit Fibromyalgie besser als das Üben auf trockenem Land. Das geht aus einer spanisch-brasilianischen Vergleichsstudie hervor.

Wo hapert es noch bei der Umsetzung der POMGAT-Leitlinie?

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Das Risiko für Vorhofflimmern in der Bevölkerung steigt

02.05.2024 Vorhofflimmern Nachrichten

Das Risiko, im Lauf des Lebens an Vorhofflimmern zu erkranken, ist in den vergangenen 20 Jahren gestiegen: Laut dänischen Zahlen wird es drei von zehn Personen treffen. Das hat Folgen weit über die Schlaganfallgefährdung hinaus.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.